Xylazine, or “tranq,” is a veterinary anesthetic recognized as a highly potent and potentially lethal adulterant in community supplies of opioids, benzodiazepines, and cocaine.1 Here, we report a case that suggests a xylazine-induced masking of benzodiazepine withdrawal, which resulted in a withdrawal seizure in our patient.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile